phase two
Showing 1 - 1 of 1
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, Early Stage, Anlotinib Trial in Guangzhou (Sintilimab)
Completed
- Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
- +7 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Jun 6, 2022